Outset Medical, Inc. (OM)

Outset Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	115.27	113.69	130.38	115.38	102.6	49.94
Revenue Growth (YoY)	-7.84%	-12.80%	13.00%	12.45%	105.47%	231.18%
Cost of Revenue	73.59	74.55	101.25	97.54	94.99	62.97
Gross Profit	41.69	39.14	29.13	17.83	7.61	-13.04
Selling, General & Admin	101.59	110.67	139.8	130	101.39	75.58
Research & Development	30.29	36.29	56.57	48.86	36.74	28.85
Operating Expenses	131.87	146.96	196.37	178.85	138.13	104.43
Operating Income	-90.19	-107.82	-167.24	-161.02	-130.52	-117.47
Interest Expense	-21.46	-23.87	-12.68	-3.57	-1.72	-2.89
Interest & Investment Income	8.64	9.76	10.17	3.29	0.5	0.53
Other Non Operating Income (Expenses)	-	-	-	-	-	-0.09
EBT Excluding Unusual Items	-103.01	-121.93	-169.74	-161.29	-131.74	-119.93
Merger & Restructuring Charges	-2.68	-5.56	-2.53	-	-	-
Other Unusual Items	-7.69	-	-	-1.37	-	-1.57
Pretax Income	-113.37	-127.49	-172.27	-162.66	-131.74	-121.49
Income Tax Expense	0.44	0.49	0.52	0.3	0.2	-
Earnings From Continuing Operations	-	-127.98	-172.8	-162.96	-131.94	-121.49
Net Income	-113.82	-127.98	-172.8	-162.96	-131.94	-121.49
Preferred Dividends & Other Adjustments	-	-	-	-	-	-42.17
Net Income to Common	-113.82	-127.98	-172.8	-162.96	-131.94	-79.32
Shares Outstanding (Basic)	4	3	3	3	3	1
Shares Outstanding (Diluted)	4	3	3	3	3	1
Shares Change (YoY)	30.94%	4.76%	2.96%	5.64%	178.69%	1806.53%
EPS (Basic)	-26.02	-36.95	-52.27	-50.75	-43.41	-72.74
EPS (Diluted)	-26.02	-36.95	-52.27	-50.75	-43.41	-72.74
Free Cash Flow	-96.74	-117.22	-134.81	-154.05	-133.37	-108.09
Free Cash Flow Per Share	-22.11	-33.84	-40.78	-47.98	-43.88	-99.12
Gross Margin	36.16%	34.43%	22.34%	15.46%	7.41%	-26.11%
Operating Margin	-78.24%	-94.84%	-128.27%	-139.56%	-127.21%	-235.24%
Profit Margin	-98.73%	-112.57%	-132.54%	-141.24%	-128.59%	-158.85%
Free Cash Flow Margin	-83.92%	-103.10%	-103.40%	-133.53%	-129.99%	-216.47%
EBITDA	-84.63	-102.09	-161.43	-155.85	-125.36	-114.31
EBITDA Margin	-73.41%	-89.80%	-123.82%	-135.08%	-122.18%	-228.91%
D&A For EBITDA	5.56	5.73	5.81	5.17	5.16	3.16
EBIT	-90.19	-107.82	-167.24	-161.02	-130.52	-117.47
EBIT Margin	-78.24%	-94.84%	-128.27%	-139.56%	-127.21%	-235.24%
Revenue as Reported	115.27	113.69	130.38	115.38	102.6	49.94

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q